Natera Inc (NAS:NTRA)
$ 162.39 0.4 (0.25%) Market Cap: 21.44 Bil Enterprise Value: 20.99 Bil PE Ratio: 0 PB Ratio: 22.95 GF Score: 70/100

Natera, Inc. - Special Call Transcript

Oct 10, 2019 / 08:30PM GMT
Release Date Price: $35.59 (+4.55%)
Operator

Welcome to the conference call. (Operator Instructions) As a reminder, this conference call is being recorded today, October 10, 2019. I would now like to turn the conference over to Tami Chen, Lead Counsel. Please go ahead.

Tami Chen;Lead Counsel;Natera
Inc.,

Thanks, operator. Good afternoon. Thank you for joining our conference call. Also on the line is Steve Chapman, CEO; Mike Brophy, CFO; Solomon Moshkevich, General Manager of Oncology and Transplant Diagnostics; and Dr. Alex Aleshin, Senior Medical Director for Oncology.

Today's conference call is being broadcast live via webcast. We will be referring to a slide presentation that has been posted to investor.natera.com. A replay of the call will also be available at investor.natera.com.

During the course of this conference call, we will make forward-looking statements regarding future events like market sizes, partnerships, clinical studies, opportunities and strategies and expectations for various current and future products. We caution you that such

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot